Skip to main content
Clinical Trials/NCT02632578
NCT02632578
Completed
Not Applicable

A Comparison of Immune Responses to the Licensed Trivalent Inactivated Influenza Vaccine in HIV-positive and HIV-negative Subjects

University of Melbourne0 sites57 target enrollmentFebruary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Influenza, Human
Sponsor
University of Melbourne
Enrollment
57
Primary Endpoint
Anti-influenza antibody responses in plasma with Fc-mediated functions
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The aims of this study are:

  1. to investigate if HIV infection alters the antibody responses to influenza and
  2. to assess the ability of licensed influenza vaccine to induce functional non-neutralising antibodies in HIV-infected and HIV-uninfected subjects.
Registry
clinicaltrials.gov
Start Date
February 2015
End Date
December 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Prof Stephen Kent

Professor

University of Melbourne

Eligibility Criteria

Inclusion Criteria

  • HIV-1 positive by licensed diagnostic test (for HIV-positive group only)
  • Planning to receive the seasonal influenza vaccine outside the study
  • Provision of written informed consent

Exclusion Criteria

  • Previous allergy to influenza vaccination
  • Pregnancy or planning to become pregnant
  • Unwilling or unable to provide blood samples

Outcomes

Primary Outcomes

Anti-influenza antibody responses in plasma with Fc-mediated functions

Time Frame: Four weeks after influenza vaccination

Similar Trials